LMC Diabetes & Endocrinology

Profil Institute, LMC Diabetes partnership on cross-border multi-site trials

Wednesday, June 15, 2016

Profil Institute for Clinical Research, a science-driven CRO focused exclusively on metabolic diseases, and LMC Diabetes & Endocrinology, North America’s largest network of investigator sites for diabetes clinical research, have announced a strategic alliance focused on the conduct of cross-border, multi-site clinical research of investigational drugs and devices for diabetes and related metabolic disorders.

[Read More]